# A Comparative Study of KSO-0400 in BPH Patients With LUTS

> **NCT01222650** · PHASE2 · COMPLETED · sponsor: **Kissei Pharmaceutical Co., Ltd.** · enrollment: 400 (—)

## Conditions studied

- Benign Prostatic Hyperplasia (BPH)

## Interventions

- **DRUG:** KSO-0400
- **DRUG:** KSO-0400
- **DRUG:** Silodosin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01222650
- **Lead sponsor:** Kissei Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 400 (—)
- **Last updated:** 2011-07-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01222650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01222650, "A Comparative Study of KSO-0400 in BPH Patients With LUTS". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01222650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*